Mortality and Prognosis in Hepatic Encephalopathy

1. Overall Mortality Drivers

• Patients with hepatic encephalopathy (HE) primarily die from complications of the underlying liver disease rather than from the encephalopathy itself; the most frequent causes are cardiovascular events, infections, hepatorenal syndrome, and variceal bleeding. 1

2. Prognostic Significance of HE

• HE serves as a marker of poor prognosis, indicating severe liver insufficiency and portosystemic shunting that predispose to life‑threatening complications. 1, 2
• Without successful treatment of the underlying liver disease, HE is associated with reduced survival and a high likelihood of recurrence. 1, 2
• The presence of overt HE defines the decompensated phase of cirrhosis and markedly increases mortality risk. 1

3. Specific Causes of Death

3.1 Cardiovascular Mortality

• Cardiovascular death is the leading cause of mortality in cirrhotic patients with HE, accounting for approximately 50 %–65 % of deaths, with variation according to left‑ventricular ejection fraction status. 3
• Mortality related to heart failure is especially high in patients with reduced ejection fraction (≈ 70 %) compared with those with preserved ejection fraction (≈ 45 %). 3

3.2 Infectious Complications

• Bacterial infections occur in 60 %–80 % of individuals with acute liver failure and HE; fungal infections develop in about one‑third of these cases. 4
• Infections act as a major precipitating factor for HE episodes and constitute a direct cause of death in decompensated cirrhosis. 4

3.3 Hepatorenal Syndrome

• Hepatorenal syndrome frequently co‑exists with HE in decompensated cirrhosis and represents a terminal complication. 5, 4

3.4 Variceal Bleeding

• Gastrointestinal bleeding from esophageal or gastric varices both precipitates HE and serves as a direct cause of death. 1
• Variceal hemorrhage is a major complication that often necessitates referral to transplant centers. 5

4. Mortality Rates and Prognostic Indicators

4.1 Acute Liver Failure with HE

• Survival without transplantation is 10 %–20 %; liver transplantation improves survival to 75 %–80 % at 1 year and 70 % at 5 years. 5
• Prognosis in acute liver failure is primarily determined by the grade of encephalopathy and the extent of multi‑organ dysfunction. 5

4.2 Chronic Liver Disease with HE

• Cirrhotic patients admitted to intensive care have an in‑hospital mortality of 30 %–50 %. 4
• After a first overt HE episode, the 1‑year cumulative mortality risk is substantial, with a 40 % chance of recurrent episodes. 1, 6
• Even with lactulose therapy, patients experiencing recurrent overt HE have a 40 % cumulative risk of another recurrence within 6 months. 1, 6

5. Clinical Pitfalls and Direct Effects of HE

• HE rarely causes death directly, except in cases of severe cerebral edema associated with acute liver failure. 4
• Neuropsychiatric manifestations of HE (e.g., confusion, coma) increase the risk of aspiration pneumonia, falls, and failure to recognize other life‑threatening conditions. 1
• Advanced HE (stupor or coma) predisposes patients to aspiration, respiratory failure, and cerebral edema, particularly in the setting of acute liver failure. 1, 4
• Seizures are uncommon in HE but, when present, indicate severe neurological compromise. 6

6. Role of Liver Transplantation

• HE is an indication for liver‑transplant evaluation because it signals decompensated disease with limited survival without transplantation. 5
• Expected survival without transplantation in patients with recurrent HE is typically ≤ 1 year. 5
• Liver transplantation markedly improves survival by addressing both HE and the underlying liver failure. 5

Encefalopatía Hepática en la Cirrosis

Mecanismos Fisiopatológicos

• La disfunción hepática en la cirrosis reduce la capacidad del hígado para metabolizar el amoniaco producido principalmente en el intestino, lo que contribuye a la hiperamonemia 7, 8
• Los cortocircuitos portosistémicos permiten que la sangre portal rica en amoniaco evite el hígado y entre directamente en la circulación sistémica, aumentando los niveles de amoniaco en sangre 8, 9
• La hiperamonemia y la inflamación sistémica actúan sinérgicamente en el desarrollo de la encefalopatía hepática, causando alteraciones en la función cerebral 7, 8
• La sepsis puede precipitar o empeorar la encefalopatía hepática, observándose síntomas neurológicos en 21-33% de los pacientes cirróticos con sepsis 7, 9

Factores Precipitantes y Agravantes

• La hiponatremia es un factor de riesgo independiente para el desarrollo de encefalopatía hepática en pacientes con cirrosis, causando edema cerebral con hipo-osmolalidad extracelular 8, 9
• La disfunción renal reduce la excreción de amoniaco, aumentando sus niveles séricos y contribuyendo al desarrollo de encefalopatía hepática 7, 8
• La diabetes mellitus se ha sugerido como factor de riesgo para el desarrollo de encefalopatía hepática, especialmente en pacientes con cirrosis por virus de la hepatitis C 8, 9

Consideraciones Especiales

• Los pacientes con trastorno por consumo de alcohol muestran déficits en memoria episódica, funciones ejecutivas, habilidades visuoconstructivas y motoras, lo que puede ser difícil de diferenciar de la encefalopatía hepática 7, 10
• La hepatitis C puede estar presente y replicarse dentro del cerebro, causando disfunción cognitiva que involucra aprendizaje verbal, atención, función ejecutiva y memoria 7, 11

Diagnóstico y Manejo

• Es importante diferenciar la encefalopatía hepática de otras causas de alteración mental en pacientes con enfermedad hepática crónica, considerando la evolución temporal y la respuesta a la terapia 7, 12
• El monitoreo de los niveles de sodio en sangre es importante, ya que la hiponatremia grave es un factor predisponente para la encefalopatía hepática 13, 14
• Se debe limitar la prescripción de inhibidores de la bomba de protones a sus indicaciones estrictamente validadas, ya que pueden empeorar la disbiosis intestinal y aumentar la producción de amoniaco 13, 14